NCT00901290View on ClinicalTrials.gov

Determine the Effects of C-administration of AZD7325 and an Oral Contraceptive in Healthy Female Subjects

PHASE1SuspendedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Pharmacokinetics
Interventions
DRUG

monophasic oral contraceptive

mg, oral dose

DRUG

AZD7325

mg, oral dose

Trial Locations (1)

Unknown

Research Site, Overland Park

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT00901290 - Determine the Effects of C-administration of AZD7325 and an Oral Contraceptive in Healthy Female Subjects | Biotech Hunter | Biotech Hunter